CORC

浏览/检索结果: 共30条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial 期刊论文
2019, 卷号: 73, 期号: 7
作者:  Guo, Yutao;  Lane, Deirdre A.;  Wang, Liming;  Chen, Yundai;  Lip, Gregory Y. H.
收藏  |  浏览/下载:48/0  |  提交时间:2020/01/03
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer 期刊论文
2019
作者:  Xing Puyuan;  Han Xiaohong;  Wang Sha;  Liu Yutao;  Yang Sheng
收藏  |  浏览/下载:21/0  |  提交时间:2020/01/03
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma 期刊论文
2019, 卷号: 9, 页码: 556
作者:  Han, Xiaohong;  Tan, Qiaoyun;  Yang, Sheng;  Li, Junling;  Xu, Jianping
收藏  |  浏览/下载:19/0  |  提交时间:2020/01/03
Prognostic significance of molecular characteristics of cerebrospinal fluid for non-small cell lung cancer patients with leptomeningeal metastasis 期刊论文
2019, 卷号: 10, 期号: 8, 页码: 1673-1682
作者:  Li, Ning;  Liu, Yutao;  Duan, Jianchun;  Yang, Boyan;  Bai, Hua
收藏  |  浏览/下载:24/0  |  提交时间:2020/01/03
Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer 期刊论文
2019, 卷号: 18, 期号: 3, 页码: 3159-3169
作者:  Liu Yutao;  Xu Fang;  Wang Yubo;  Wu Qingchen;  Wang Buhai
收藏  |  浏览/下载:30/0  |  提交时间:2020/01/03
Clinicopathologic characteristics and outcome of patients with different EGFR mutations 期刊论文
2019, 卷号: 15, 期号: 3, 页码: 166-171
作者:  Zhou, Shengyu;  Hu, Xingsheng;  Wang, Yan;  Li, Junling;  Zhou, Liqiang
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib 期刊论文
2019, 卷号: 129, 页码: 92-94
作者:  Liu, Yutao;  Liu, Tianfeng;  Li, Nan;  Wang, Tao;  Pu, Yue
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
Heterogeneity-based, multiple mechanisms in the resistance to osimertinib (AZD9291): A case report 期刊论文
2018, 卷号: 9, 期号: 4, 页码: 498-501
作者:  Liu, Yutao;  Hao, Xuezhi;  Hu, Xingsheng;  Li, Junling;  Wang, Yan
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/03
Combination TS-1 plus EGFR-tyrosine kinase inhibitors (TKIs) for the treatment of non-small cell lung cancer after progression on first-line or further EGFR-TKIs: A phase II, single-arm trial 期刊论文
2018, 卷号: 9, 期号: 6, 页码: 693-698
作者:  Yang, Lu;  Yang, Sheng;  Liu, Yutao;  Li, Junling;  Hu, Xingsheng
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Acquired &ITEGFR&IT L718V mutation mediates resistance to osimertinib in non-small cell lung cancer but retains sensitivity to afatinib 期刊论文
2018, 卷号: 118, 页码: 1-5
作者:  Liu, Yutao;  Li, Yan;  Ou, Qiuxiang;  Wu, Xue;  Wang, Xiaonan
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace